InspireMD's top three insider shareholders as of September 29, 2026 are Marvin Slosman (Ceo And President, 3.56Mn shares), Marvin Slosman (Ceo And President, 3.54Mn shares), Shane Thomas Gleason (Chief Commercial Officer, 1.14Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Marvin Slosman | Ceo And President | 7,092,316 | 0 | 7,092,316 | 49.3% | 13 May, 2026 |
| 2 | Shane Thomas Gleason | Chief Commercial Officer | 1,139,177 | 0 | 1,139,177 | 7.9% | 02 Feb, 2026 |
| 3 | Craig Shore | Cfo And Cao | 1,112,460 | 0 | 1,112,460 | 7.7% | 10 Jan, 2025 |
| 4 | Andrea Tommasoli | Chief Operating Officer | 954,389 | 0 | 954,389 | 6.6% | 16 Jan, 2026 |
| 5 | Gary S Roubin | Director | 834,478 | 0 | 834,478 | 5.8% | 08 May, 2026 |
| 6 | Michael A Lawless | Chief Financial Officer | 691,695 | 0 | 691,695 | 4.8% | 16 Jan, 2026 |
| 7 | Paul Stuka | Director | 667,871 | 0 | 667,871 | 4.6% | 29 May, 2026 |
| 8 | Thomas J Kester | Director | 458,573 | 0 | 458,573 | 3.2% | 17 Sep, 2025 |
| 9 | Michael Berman | Director | 352,586 | 0 | 352,586 | 2.5% | 16 Jan, 2026 |
| 10 | Patrick Verta | Evp Clinical/Medical Affairs | 311,532 | 0 | 311,532 | 2.2% | 10 Jan, 2025 |
| 11 | Kathryn Arnold | Director | 303,087 | 0 | 303,087 | 2.1% | 31 Dec, 2025 |
| 12 | Scott R. Ward | Director | 237,096 | 0 | 237,096 | 1.6% | 08 May, 2026 |
| 13 | Danny L. Dearen | Director | 102,047 | 0 | 102,047 | 0.7% | 16 Jan, 2026 |
| 14 | Raymond W Cohen | Director | 92,417 | 0 | 92,417 | 0.6% | 16 Jan, 2026 |
| 15 | Campbell Rogers | Director | 27,960 | 0 | 27,960 | 0.2% | 14 Oct, 2021 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 18 Sep, 2026 | Paul Stuka | Director | Disposed J | 43,750 | $0.00 | $0 | 43,750 | Indirect |
| 18 Sep, 2026 | Michael Berman | Director | Disposed J | 30,625 | $0.00 | $0 | 30,624 | Indirect |
| 18 Sep, 2026 | Gary S Roubin | Director | Disposed J | 15,313 | $0.00 | $0 | 15,312 | Direct |
| 18 Sep, 2026 | Michael Berman | Director | Acquired J | 30,625 | $0.00 | $0 | 30,625 | Indirect |
| 18 Sep, 2026 | Gary S Roubin | Director | Acquired J | 15,313 | $0.00 | $0 | 15,313 | Direct |
| 18 Sep, 2026 | Paul Stuka | Director | Acquired J | 43,750 | $0.00 | $0 | 43,750 | Indirect |
| 18 Sep, 2026 | Michael Berman | Director | Disposed J | 61,248 | $0.00 | $0 | 0 | Indirect |
| 18 Sep, 2026 | Paul Stuka | Director | Disposed J | 87,500 | $0.00 | $0 | 0 | Indirect |
| 18 Sep, 2026 | Gary S Roubin | Director | Disposed J | 30,624 | $0.00 | $0 | 0 | Direct |
| 18 Sep, 2026 | Michael Berman | Director | Acquired J | 61,248 | $0.00 | $0 | 61,248 | Indirect |
| 18 Sep, 2026 | Paul Stuka | Director | Acquired J | 87,500 | $0.00 | $0 | 43,750 | Indirect |
| 18 Sep, 2026 | Gary S Roubin | Director | Acquired J | 30,624 | $0.00 | $0 | 30,624 | Direct |
| 27 May, 2026 | Paul Stuka | Director | Acquired P | 20,000 | $0.88 | $17.50K | 667,871 | Direct |
| 13 May, 2026 | Paul Stuka | Director | Acquired P | 10,000 | $1.16 | $11.58K | 642,871 | Direct |
| 14 May, 2026 | Paul Stuka | Director | Acquired P | 5,000 | $1.15 | $5.75K | 647,871 | Direct |
| 12 May, 2026 | Marvin Slosman | Ceo And President | Acquired P | 21,000 | $1.20 | $25.20K | 3,556,658 | Direct |
| 08 May, 2026 | Paul Stuka | Director | Acquired P | 65,626 | $1.16 | $76.13K | 622,871 | Direct |
| 11 May, 2026 | Paul Stuka | Director | Acquired P | 10,000 | $1.19 | $11.90K | 632,871 | Direct |
| 08 May, 2026 | Paul Stuka | Director | Acquired P | 65,626 | $1.16 | $76.13K | 622,871 | Direct |
| 11 May, 2026 | Paul Stuka | Director | Acquired P | 10,000 | $1.19 | $11.90K | 632,871 | Direct |